Novartis Investigative Site

HUS FIN-00029

0 studies enrolling now · 6 studies all time

What they study most

Acute Myeloid Leukemia (AML), Asthma, Chronic Obstructive Pulmonary Disease (COPD), Endometrial Carcinoma, Heart Failure With Reduced Ejection Fraction, Liver Transplantation, Melanoma, Multiple Myeloma (MM), Non-Hodgkin Lymphoma (NHL), Pancreatic Carcinoma, Triple Negative Breast Cancer

Studies at this site

• VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma) — Stopped early
• Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies — Completed
• Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients — Completed
• Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early
• A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation — Completed